![](/img/cover-not-exists.png)
0161 Letrozole vs. tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Update of the BIG 1-98 primary core analysis
B. ThürlimannVolume:
18
Year:
2009
Language:
english
Pages:
1
DOI:
10.1016/s0960-9776(09)70192-4
File:
PDF, 53 KB
english, 2009